Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.6065/apem.2013.18.1.36 http://scihub22266oqcxt.onion/10.6065/apem.2013.18.1.36 C4027064!4027064!24904849     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Pediatr+Endocrinol+Metab 2013 ; 18 (1): 36-9 Nephropedia Template TP {{tp|p=24904849|t=2013. Gitelman syndrome combined with complete growth hormone deficiency |pdf=|usr=}}{{24904849}} gab.com Text Gitelman syndrome combined with complete growth hormone deficiency JO: Ann Pediatr Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=24904849 #FOAvip Gitelman syndrome is a rare autosomal recessive hereditary salt-losing tubulopathy, that manifests as hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria. It is caused by mutations in the solute carrier family 12(sodium/chloride transporters), member 3 (SLC12A3) gene encoding the thiazide-sensitive sodium chloride cotransporter channel (NCCT) in the distal convoluted tubule of the kidney. It is associated with muscle weakness, cramps, tetany, vomiting, diarrhea, abdominal pain, and growth retardation. The incidence of growth retardation, the exact cause of which is unknown, is lower than that of Bartter syndrome. Herein, we discuss the case of an overweight 12.9-year-old girl of short stature presenting with hypokalemic metabolic alkalosis. The patient, on the basis of detection of a heterozygous mutation in the SLC12A3 gene and poor growth hormone (GH) responses in two provocative tests, was diagnosed with Gitelman syndrome combined with complete GH deficiency. GH treatment accompanied by magnesium oxide and potassium replacement was associated with a good clinical response. Twit Text FOAVip Gitelman syndrome combined with complete growth hormone deficiency ????Ann Pediatr Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=24904849 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24904849 #FOAvip English Wikipedia <ref>{{Cite pmid|24904849}}</ref> Gitelman syndrome combined with complete growth hormone deficiency #MMPMID24904849 Min SR; Cho HS; Hong J; Cheong HI; Ahn SY Ann Pediatr Endocrinol Metab 2013[Mar]; 18 (1): 36-9 PMID24904849show ga Gitelman syndrome is a rare autosomal recessive hereditary salt-losing tubulopathy, that manifests as hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria. It is caused by mutations in the solute carrier family 12(sodium/chloride transporters), member 3 (SLC12A3) gene encoding the thiazide-sensitive sodium chloride cotransporter channel (NCCT) in the distal convoluted tubule of the kidney. It is associated with muscle weakness, cramps, tetany, vomiting, diarrhea, abdominal pain, and growth retardation. The incidence of growth retardation, the exact cause of which is unknown, is lower than that of Bartter syndrome. Herein, we discuss the case of an overweight 12.9-year-old girl of short stature presenting with hypokalemic metabolic alkalosis. The patient, on the basis of detection of a heterozygous mutation in the SLC12A3 gene and poor growth hormone (GH) responses in two provocative tests, was diagnosed with Gitelman syndrome combined with complete GH deficiency. GH treatment accompanied by magnesium oxide and potassium replacement was associated with a good clinical response. äGitelman syndrome combined with complete growth hormone deficiency (epmc).pdf DeepDyve Pubget Overpricing